Next Article in Journal
Determinants of Farm Resilience to Climate Change: The Role of Farmer Entrepreneurship and Value Chain Collaborations
Previous Article in Journal
Searching for the Center: A New Civic Role for the Central Business District in China
Open AccessArticle

International Strategy for Sustainable Growth in Multinational Pharmaceutical Companies

1
Graduate School of Technology Management, Ritsumeikan University, Osaka 567-8570, Japan
2
Eli Lilly Japan K.K., Hyogo 651-0086, Japan
3
Faculty of Business Administration, Ritsumeikan University, Osaka 567-8570, Japan
4
School of Environment and Society, Tokyo Institute of Technology, Tokyo 152-8550, Japan
*
Authors to whom correspondence should be addressed.
Sustainability 2020, 12(3), 867; https://doi.org/10.3390/su12030867
Received: 25 December 2019 / Revised: 15 January 2020 / Accepted: 21 January 2020 / Published: 23 January 2020
(This article belongs to the Section Economic and Business Aspects of Sustainability)
Although it is generally agreed that the pharmaceutical industry is in a state of rapid internationalization, there is no clear comprehensive explanation of the current state and effectiveness of an international strategy. There are many studies about internationalization but they neither focus on the pharmaceutical industry nor evaluate the effectiveness of an international strategy with a control. Therefore, we investigate the current state of internationalization with a sample of the 30 multinational pharmaceutical companies, as well as the effectiveness of an international strategy by comparing two international strategies. In this study, we define an international strategy as a strategy that controls the geographic distribution of sales across regions to maximize total sales. The results show that 33% of the companies are still home-region-oriented, and we did not find any evidence of the effectiveness of an international strategy that pursues a balanced geographic distribution across regions in terms of total sales and adjusted total sales. The results provide the practical implication that pharmaceutical companies should weigh up the specific markets to secure higher sales through the advantage of adapting to customers’ needs. This paper contributes to the research on sustainable growth by empirically providing results of comparisons of different international strategies in the pharmaceutical industry. View Full-Text
Keywords: pharmaceutical industry; strategy implementation; globalization; growth assessment; comparison results pharmaceutical industry; strategy implementation; globalization; growth assessment; comparison results
Show Figures

Figure 1

MDPI and ACS Style

Teramae, F.; Makino, T.; Lim, Y.; Sengoku, S.; Kodama, K. International Strategy for Sustainable Growth in Multinational Pharmaceutical Companies. Sustainability 2020, 12, 867.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop